A tumor treatment strategy based on biodegradable BSA@ZIF-8 for simultaneously ablating tumors and inhibiting infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A tumor treatment strategy based on biodegradable BSA@ZIF-8 for simultaneously ablating tumors and inhibiting infection

Published:2018 Issue:6 Volume:3 Page:606-615
ISSN:2055-6756
Container-title:Nanoscale Horizons
language:en
Short-container-title:Nanoscale Horiz.

Author:

Wu Qiong¹²³⁴⁵,Li Mei⁶⁷⁸⁹¹⁰,Tan Longfei¹²³⁴⁵,Yu Jie¹¹¹²¹³¹⁴,Chen Zengzhen¹²³⁴⁵,Su Liuhui¹²³⁴⁵,Ren Xiangling¹²³⁴⁵,Fu Changhui¹²³⁴⁵,Ren Jun¹²³⁴⁵,Li Laifeng¹²³⁴⁵,Cao Feng¹⁵¹²¹³¹⁴,Liang Ping¹¹¹²¹³¹⁴^ORCID,Zhang Yu⁶⁷⁸⁹¹⁰,Meng Xianwei¹²³⁴⁵^ORCID

Affiliation:

1. Laboratory of Controllable Preparation and Application of Nanomaterials

2. Key Laboratory of Cryogenics

3. Technical Institute of Physics and Chemistry

4. Chinese Academy of Sciences

5. Beijing 100190

6. Department of Orthopedics

7. Guangdong General Hospital

8. Guangdong Academy of Medical Sciences

9. Guangzhou 510080

10. China

11. Department of Interventional Ultrasound

12. Chinese PLA General Hospital

13. Beijing 100853

14. P. R. China

15. Department of Cardiology

Abstract

Biodegradable BSA@ZIF-8 can treat cancer by tumor microwave ablation, while simultaneously inhibiting bacteria and resisting infection.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2018/NH/C8NH00113H

Reference66 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

3. Global cancer statistics, 2012

4. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

5. Noninvasive small-animal imaging of galectin-1 upregulation for predicting tumor resistance to radiotherapy

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tunable Zeolitic Imidazolate Framework‐8 Nanoparticles for Biomedical Applications;Small Methods;2023-11-23

2. Degradation Kinetic Studies of BSA@ZIF-8 Nanoparticles with Various Zinc Precursors, Metal-to-Ligand Ratios, and pH Conditions;ACS Omega;2023-11-16

3. Sequential Anti-Infection and Proangiogenesis of DMOG@ZIF-8/Gelatin-PCL Electrospinning Dressing for Chronic Wound Healing;ACS Applied Materials & Interfaces;2023-10-16

4. Multifunctional 3D-printed scaffolds eradiate orthotopic osteosarcoma and promote osteogenesis via microwave thermo-chemotherapy combined with immunotherapy;Biomaterials;2023-10

5. A bright future: Advanced nanotechnology-assisted microwave therapy;Nano Today;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3